What is it about?
The role of perioperative radiation for retroperitoneal sarcoma is controversial. We used a large national database to evaluate which clinical and pathological factors might be associated with an improvement in overall survival with perioperative radiation therapy.
Featured Image
Photo by Fabio Ballasina on Unsplash
Why is it important?
We define clinical and pathological predictors for selecting which patients with retroperitoneal sarcomas may benefit most from perioperative radiation therapy
Read the Original
This page is a summary of: Radiation Therapy for Retroperitoneal Sarcomas: Influences of Histology, Grade, and Size, Sarcoma, December 2018, Hindawi Publishing Corporation,
DOI: 10.1155/2018/7972389.
You can read the full text:
Contributors
The following have contributed to this page
